Platforms And Techniques Used For Biomarker Assays: Where Are We Now?
Charles Hottenstein, Matthew Szapacs, Kerensa Fuller & Christopher Evans
Bioanlysis Vol. 9 No. 14
The biomarker bioanalyst now has the tools that are critical to address and resolve the unique biological questions and challenges that exist over the course of the drug development process.
Share this page